Retatrutide 60mg

Significant Weight Reduction: Clinical trials indicate that participants on high-dose retatrutide lost an average of 17.5% of their body weight at 24 weeks, with reductions reaching over 24% at 48 weeks.
Triple-Hormone Mechanism: Unlike semaglutide (GLP-1) or tirzepatide (GLP-1/GIP), retatrutide adds glucagon receptor agonism, which increases energy expenditure and helps burn more fat.
Improved Metabolic Health & Diabetes Management: It improves glycemic control, reduces HbA1c levels, and boosts insulin sensitivity.
Cardiovascular and Liver Benefits: Studies suggest reductions in blood pressure, improvement in cholesterol levels, and a decrease in liver fat (beneficial for MASLD/NAFLD).
Appetite Suppression: The peptide reduces hunger and cravings, making it easier to maintain a lower calorie intake.
Muscle-Sparing Potential: Evidence suggests that despite rapid weight loss, the compound may help preserve lean muscle mass.
Side Effects and Considerations

Important: This product is sold strictly for research use only. It is not for human or animal consumption, and it is not intended for diagnostic, therapeutic, clinical, or veterinary use. By purchasing, you confirm that you are buying for lawful laboratory research purposes only.